IRS4 (insulin receptor substrate 4)

2007-02-01  

Identity

HGNC
LOCATION
Xq22.3
LOCUSID
ALIAS
CHNG9,IRS-4,PY160
FUSION GENES

Other Information

Locus ID:

NCBI: 8471
MIM: 300904
HGNC: 6128
Ensembl: ENSG00000133124

Variants:

dbSNP: 8471
ClinVar: 8471
TCGA: ENSG00000133124
COSMIC: IRS4

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000133124ENST00000372129O14654

Expression (GTEx)

0
1
2
3
4
5
6
7
8
9
10

Pathways

PathwaySourceExternal ID
Autophagy - animalKEGGko04140
Insulin signaling pathwayKEGGko04910
Adipocytokine signaling pathwayKEGGko04920
Type II diabetes mellitusKEGGko04930
Autophagy - animalKEGGhsa04140
Insulin signaling pathwayKEGGhsa04910
Adipocytokine signaling pathwayKEGGhsa04920
Type II diabetes mellitusKEGGhsa04930
FoxO signaling pathwayKEGGhsa04068
cGMP-PKG signaling pathwayKEGGhsa04022
cGMP-PKG signaling pathwayKEGGko04022
AMPK signaling pathwayKEGGhsa04152
AMPK signaling pathwayKEGGko04152
Regulation of lipolysis in adipocytesKEGGhsa04923
Signal TransductionREACTOMER-HSA-162582
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)REACTOMER-HSA-2404192
IGF1R signaling cascadeREACTOMER-HSA-2428924
IRS-related events triggered by IGF1RREACTOMER-HSA-2428928
Longevity regulating pathwayKEGGhsa04211
Longevity regulating pathway - multiple speciesKEGGko04213
Longevity regulating pathway - multiple speciesKEGGhsa04213

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
368601952023Further Delineation of Central Congenital Hypothyroidism due to Variants in TBL1X and IRS4.0
368601952023Further Delineation of Central Congenital Hypothyroidism due to Variants in TBL1X and IRS4.0
355502472022FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cells.7
357439852022Patients with Invasive Lobular Carcinoma Show a Significant Increase in IRS-4 Expression Compared to Infiltrative Ductal Carcinoma-A Histopathological Study.1
355502472022FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cells.7
357439852022Patients with Invasive Lobular Carcinoma Show a Significant Increase in IRS-4 Expression Compared to Infiltrative Ductal Carcinoma-A Histopathological Study.1
338942212021IRS4 promotes the progression of non-small cell lung cancer and confers resistance to EGFR-TKI through the activation of PI3K/Akt and Ras-MAPK pathways.10
340934352021Screening for Mutations in Isolated Central Hypothyroidism Reveals a Novel Mutation in Insulin Receptor Substrate 4.2
345909202021Chronic venous disease patients show increased IRS-4 expression in the great saphenous vein wall.5
338942212021IRS4 promotes the progression of non-small cell lung cancer and confers resistance to EGFR-TKI through the activation of PI3K/Akt and Ras-MAPK pathways.10
340934352021Screening for Mutations in Isolated Central Hypothyroidism Reveals a Novel Mutation in Insulin Receptor Substrate 4.2
345909202021Chronic venous disease patients show increased IRS-4 expression in the great saphenous vein wall.5
291852292018Overexpression of insulin receptor substrate-4 is correlated with clinical staging in colorectal cancer patients.8
300268722018Phosphorylation of IRS4 by CK1γ2 promotes its degradation by CHIP through the ubiquitin/lysosome pathway.11
300613702018Mutations in IRS4 are associated with central hypothyroidism.14

Citation

Dessen P

IRS4 (insulin receptor substrate 4)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/43671/irs4-(insulin-receptor-substrate-4)